Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta 3 agonist treatment in heart failure
2012-004805-29Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of mirabegron in heart failure (HF), sponsored by Rigshospitalet. Started May 2013; status: completed.
02
Drugs
mirabegron
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2012-004805-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004805-29.